N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-[(1-methyl-4-piperidinyl)methoxy]-4-quinazolinamine(CAS: 443913-73-3)

N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-[(1-methyl-4-piperidinyl)methoxy]-4-quinazolinamine (CAS: 443913-73-3) is a synthetic organic compound with a complex molecular structure. It contains a quinazoline ring system substituted with bromo, fluoro, methoxy, and a piperidine-derived methoxy group. This compound is known for its potential pharmaceutical applications and is often studied in drug development research.

The compound is primarily used in pharmaceutical research as a potential inhibitor of certain enzymes, particularly in the development of drugs targeting neurological and inflammatory conditions. It may also be used in chemical synthesis as a building block for more complex molecules. Its applications are still under investigation due to its novel structure and biological activity.

Safety data for this compound is limited, but it is generally considered to have potential toxicity due to its complex chemical structure. Precautions include wearing appropriate personal protective equipment (PPE) and handling in a well-ventilated area. It should be used in accordance with standard chemical safety protocols and regulatory guidelines to ensure safe handling and minimize exposure risks.

This compound should be stored in a cool, dry, and dark place, preferably at 2-8°C. It is sensitive to moisture and light, so it should be kept in a sealed container with desiccant and protected from direct sunlight. Storage conditions should also ensure good ventilation and avoid contact with incompatible materials to maintain stability and safety.